Harte Hanks Inc. (NASDAQ: HHS) suffers from extremely meaningful negative changes in investment behavior: its shorter term price trend turned down, and the stock fell on very heavy volume.
Important negative changes in fundamentals have recently occurred for Harte Hanks Inc. (NASDAQ: HHS): the consensus estimate for December, 2024 decreased significantly, and significant quarterly earnings deceleration occurred.
The stock is currently unrated.
Current PriceTarget Research Rating
With future capital returns forecasted to be below the cost of capital, HHS is expected to be a major Value Eraser.
Harte Hanks is currently unrated.
Recent Price Action
On 4/3/24, Harte Hanks Inc. (NASDAQ: HHS) stock declined modestly by -1.3%, closing at $6.99. Moreover, this decline was accompanied by exceptionally high trading volume at 300% of normal. Relative to the market the stock has been exceptionally strong over the last nine months but has declined -5.4% during the last week.